HBV cccDNA: The Molecular Reservoir of Hepatitis B Persistence and Challenges to Achieve Viral Eradication
Hepatitis B virus (HBV) is a major global health issue, with an estimated 254 million people living with chronic HBV infection worldwide as of 2022. Chronic HBV infection is the leading cause of cirrhosis and liver cancer. Current treatment with nucleos(t)ide analogs is effective in the suppression...
Saved in:
| Main Authors: | André Boonstra, Gulce Sari |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Biomolecules |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/15/1/62 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic interventions aimed at cccDNA: unveiling mechanisms and evaluating the potency of natural products
by: Liyuan Hao, et al.
Published: (2025-06-01) -
Association between intrahepatic cccDNA and the severity of liver inflammation in chronic hepatitis B virus infection patients
by: Suxian Zhao, et al.
Published: (2025-01-01) -
Targeting HBV cccDNA Levels: Key to Achieving Complete Cure of Chronic Hepatitis B
by: Wei He, et al.
Published: (2024-12-01) -
Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression
by: Yang-Hsiang Lin, et al.
Published: (2025-06-01) -
cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B
by: Patricia Gita Naully, et al.
Published: (2025-01-01)